XML 112 R96.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity - Performance-Based Stock Options (Details) - Performance-Based Stock Options [Member]
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Stock-based compensation  
Contractual term 10 years
Number of Shares  
Granted (in shares) | shares 1,640,000
Outstanding at the end of the period (in shares) | shares 1,640,000
Weighted Average Exercise Price  
Granted (in dollars per share) | $ / shares $ 6.77
Outstanding at the end of the period (in dollars per share) | $ / shares $ 6.77
Additional option disclosures  
Outstanding at the end of the period, weighted average remaining contractual term 9 years 11 months 8 days
Total unrecognized compensation cost related to non-vested shares $ 6.6
Total fair value of shares vested $ 0.0
Weighted-average assumption used for grants  
Dividend yield 0.00%
Expected volatility 77.10%
Risk-free interest rate 1.36%
Expected life 6 years 2 months 12 days
Stock-based compensation  
Weighted-average grant date fair values of options granted (in dollars per share) | $ / shares $ 4.58
Exercised during the period, aggregate intrinsic value $ 0.0
Stock-based compensation expense $ 1.0